Results 61 to 70 of about 146,670 (267)
Elastographic presentation of medullary thyroid carcinoma [PDF]
, 2013 Aim of the study was to evaluate the elastographic appearance of medullary thyroid carcinoma (MTC) by a retrospective evaluation of 18 nodules histologically proven as MTC. Free-hand qualitative elastography was performed using Hitachi Logos EUB 7500.
Amendola, Stefano +6 more
core +1 more source
Medullary Thyroid Cancer [PDF]
Cancer Control, 1997 BackgroundMedullary thyroid cancer, a tumor of the parafollicular C cells, accounts for approximately 10% of all thyroid malignancies. An estimated 75% of cases are sporadic, and the remaining 25% are familial.MethodsThe author reviews the clinical features and diagnostic tests for this entity, as well as the surgical treatment of recurrent or ...
openaire +1 more source
Expression of FAS/APO 1/CD 95 in thyroid tumors.
Folia Histochemica et Cytobiologica, 2007 Using immunohistochemistry, Fas/Apo-1 protein expression was investigated in thyroid cancers of 67 patients. Thyroid biopsies from twenty eight patients with benign thyroid diseases were also examined.
Waldemar Balcerzak +5 more
doaj +1 more source
Epidemiology and treatment for thyroid cancer [PDF]
, 2011 The thyroid gland produces thyroid hormones which are important in the normal regulation of the metabolism of the body. Thyroid cancer is the most common malignancy of the endocrine system consisting of several subtypes like papillary carcinoma, and ...
Hima Bindu, A., Soumya, D., Srilatha, B.
core +1 more source
Prediction of biochemical cure in patients with medullary thyroid cancer
British Journal of Surgery, 2020 The impact of number of node metastases versus metastatic lymph node ratio versus AJCC node category on biochemical cure in medullary thyroid cancer (MTC) is not well defined.
Andreas Machens +3 more
semanticscholar +1 more source
Journal of Clinical and Translational Endocrinology Case Reports, 2020 Bone Metastases are frequently reported in neuroendocrine tumors, including medullary thyroid carcinoma. The optimal management of these lesions, which can lead to serious skeletal-related events, including hypercalcemia, bone pain, fractures, and spinal
Leslie S. Eldeiry, Han-Ting Lin
doaj +1 more source
Molecular Oncology, EarlyView.Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
Cancers, 2020 Non-medullary thyroid cancer (NMTC) is a common endocrine malignancy with a genetic basis that has yet to be unequivocally established. In a recent whole-genome sequencing study of five families with occurrence of NMTCs, we shortlisted promising variants
Aayushi Srivastava +9 more
semanticscholar +1 more source
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
British Journal of Clinical Pharmacology, EarlyView.Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo [PDF]
, 2018 Lenvatinib is an oral, multitargeted tyrosine kinase inhibitor (TKI) of VEGFR1-VEGFR3, FGFR1-FGFR4, PDGFRα, RET and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) signaling networks involved in tumor angiogenesis.
Antonelli, Alessandro +16 more
core +2 more sources